Concepedia

Lynn R. Kong

LR

Statistics

Publications

3

Citations

636

H-Index

3

Active since

1997

Affiliations

University Hospital Centre Zagreb(Current)

Lynn R. Kong is an author at University Hospital Centre Zagreb specializing in medicine, pharmacotherapy, and oncology.

Top concepts

Publications per year

1997–2017

3

Publications

3

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

, , +10

Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-hodgkin's lymphoma

Lynn R. Kong, Cheng-Fang Huang, David Hakimian et al. · Cancer · 1998 · 32 citations · Full text

2-Chlorodeoxyadenosine in Cutaneous T-cell Lymphoproliferative Disorders

Lynn R. Kong, Ellen Samuelson, Steven T. Rosen et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1997 · 26 citations

, , +17

1–3 of 3